DUBLIN, Jan. 6, 2021 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that its Chief Executive Officer,
Richard Pops, will provide a
corporate overview and update at the 39th Annual J.P.
Morgan Healthcare Conference. The presentation will take place
virtually on Wednesday, Jan. 13, 2021
at 10:00 a.m. EST (3:00 p.m. GMT), followed by a question and answer
session. The live webcast may be accessed under the Investors tab
on www.alkermes.com and will be archived for 14 days.
About Alkermes plc
Alkermes plc is a fully integrated, global biopharmaceutical
company developing innovative medicines in the fields of
neuroscience and oncology. The company has a portfolio of
proprietary commercial products focused on addiction and
schizophrenia, and a pipeline of product candidates in development
for schizophrenia, bipolar I disorder, neurodegenerative disorders
and cancer. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website at
www.alkermes.com.
Contact:
Alex Braun
Investor Relations
+1 781 296 8493
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg